Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

ASCO Education

Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

30 May 2018

Description

Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.